TrialThe Journal of dermatology2023

Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.

Keiichi Yamanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.